Literature DB >> 10583471

5-HT1A and 5-HT1B receptors control the firing of serotoninergic neurons in the dorsal raphe nucleus of the mouse: studies in 5-HT1B knock-out mice.

A Evrard1, A M Laporte, M Chastanet, R Hen, M Hamon, J Adrien.   

Abstract

The characteristics of the spontaneous firing of serotoninergic neurons in the dorsal raphe nucleus and its control by serotonin (5-hydroxytryptamine, 5-HT) receptors were investigated in wild-type and 5-HT1B knock-out (5-HT1B-/-) mice of the 129/Sv strain, anaesthetized with chloral hydrate. In both groups of mice, 5-HT neurons exhibited a regular activity with an identical firing rate of 0.5-4.5 spikes/s. Intravenous administration of the 5-HT reuptake inhibitor citalopram or the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) induced a dose-dependent inhibition of 5-HT neuronal firing which could be reversed by the selective 5-HT1A antagonist N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl)cyclohe xane carboxamide (WAY 100635). Both strains were equally sensitive to 8-OH-DPAT (ED50 approximately 6.3 microgram/kg i.v.), but the mutants were less sensitive than wild-type animals to citalopram (ED50 = 0.49 +/- 0.02 and 0.28 +/- 0.01 mg/kg i.v., respectively, P < 0.05). This difference could be reduced by pre-treatment of wild-type mice with the 5-HT1B/1D antagonist 2'-methyl-4'-(5-methyl-[1,2,4]oxadiazol-3-yl)-biphenyl-4-carbox yli c acid [4-methoxy-3-(4-methyl-piperazine-1-yl)-phenyl]amide (GR 127935), and might be accounted for by the lack of 5-HT1B receptors and a higher density of 5-HT reuptake sites (specifically labelled by [3H]citalopram) in 5-HT1B-/- mice. In wild-type but not 5-HT1B-/- mice, the 5-HT1B agonists 3-(1,2,5, 6-tetrahydro-4-pyridyl)-5-propoxypyrrolo[3,2-b]pyridine (CP 94253, 3 mg/kg i.v.) and 5-methoxy-3-(1,2,3, 6-tetrahydropyridin-4-yl)-1H-indole (RU 24969, 0.6 mg/kg i.v.) increased the firing rate of 5-HT neurons (+22.4 +/- 2.8% and +13.7 +/- 6.0%, respectively, P < 0.05), and this effect could be prevented by the 5-HT1B antagonist GR 127935 (1 mg/kg i.v.). Altogether, these data indicate that in the mouse, the firing of 5-HT neurons in the dorsal raphe nucleus is under both an inhibitory control through 5-HT1A receptors and an excitatory influence through 5-HT1B receptors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10583471     DOI: 10.1046/j.1460-9568.1999.00800.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  14 in total

1.  Selective 5-HT receptor inhibition of glutamatergic and GABAergic synaptic activity in the rat dorsal and median raphe.

Authors:  Julia C Lemos; Yu-Zhen Pan; Xiaohong Ma; Christophe Lamy; Adaure C Akanwa; Sheryl G Beck
Journal:  Eur J Neurosci       Date:  2006-12       Impact factor: 3.386

2.  Description and validation of a dynamical systems model of presynaptic serotonin function: genetic variation, brain activation and impulsivity.

Authors:  Scott F Stoltenberg; Parthasarathi Nag
Journal:  Behav Genet       Date:  2010-01-29       Impact factor: 2.805

3.  The Alteration of Neonatal Raphe Neurons by Prenatal-Perinatal Nicotine. Meaning for Sudden Infant Death Syndrome.

Authors:  Verónica J Cerpa; María de la Luz O Aylwin; Sebastián Beltrán-Castillo; Eduardo U Bravo; Isabel R Llona; George B Richerson; Jaime L Eugenín
Journal:  Am J Respir Cell Mol Biol       Date:  2015-10       Impact factor: 6.914

4.  Infralimbic and dorsal raphé microinjection of the 5-HT(1B) receptor agonist CP-93,129: attenuation of aggressive behavior in CFW male mice.

Authors:  S Faccidomo; I M H Quadros; A Takahashi; E W Fish; K A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2012-01-07       Impact factor: 4.530

5.  Behavioral, neurochemical, and electrophysiological characterization of a genetic mouse model of depression.

Authors:  Malika El Yacoubi; Saoussen Bouali; Daniela Popa; Laurent Naudon; Isabelle Leroux-Nicollet; Michel Hamon; Jean Costentin; Joëlle Adrien; Jean-Marie Vaugeois
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-05       Impact factor: 11.205

6.  Blockade of serotonin 5-HT1B and 5-HT2A receptors suppresses the induction of locomotor activity by 5-HT reuptake inhibitors, citalopram and fluvoxamine, in NMRI mice exposed to a novel environment: a comparison to other 5-HT receptor subtypes.

Authors:  Mark J Millan; Sylvie Veiga; Sylvie Girardon; Mauricette Brocco
Journal:  Psychopharmacology (Berl)       Date:  2003-04-30       Impact factor: 4.530

Review 7.  Genetic variation in cortico-amygdala serotonin function and risk for stress-related disease.

Authors:  Andrew Holmes
Journal:  Neurosci Biobehav Rev       Date:  2008-03-26       Impact factor: 8.989

Review 8.  HTR1B as a risk profile maker in psychiatric disorders: a review through motivation and memory.

Authors:  Antonio Drago; Silvia Alboni; Nicoletta Brunello; Brunello Nicoletta; Diana De Ronchi; Alessandro Serretti
Journal:  Eur J Clin Pharmacol       Date:  2009-10-07       Impact factor: 2.953

9.  Modulation of anxiety by cortical serotonin 1A receptors.

Authors:  Lukasz Piszczek; Agnieszka Piszczek; Joanna Kuczmanska; Enrica Audero; Cornelius T Gross
Journal:  Front Behav Neurosci       Date:  2015-02-24       Impact factor: 3.558

10.  Role of serotonin 5-HT1A and opioid receptors in the antiallodynic effect of tramadol in the chronic constriction injury model of neuropathic pain in rats.

Authors:  Esther Berrocoso; M Dolores De Benito; Juan A Mico
Journal:  Psychopharmacology (Berl)       Date:  2007-03-29       Impact factor: 4.415

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.